Interim Report Q3 2021
After almost two years of the COVID-19 pandemic, our communities are starting to re-open. The business situation in the third quarter remained favourable, influenced by the efforts of the different countries to manage the infection. Sales in the third quarter increased by 49 percent to SEK 1,850 million and the result, EBITA, increased by 44 percent to SEK 286 million and the EBITA margin amounted to 15.5 percent. Accumulated for the interim period, sales increased by 65 percent to SEK 5,862 million and EBITA rose by 94 percent to SEK 944 million.
Labtech offers products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis.
MORE ABOUT LABTECHMedtech offers products, solutions and services in medtech and home care.
MORE ABOUT MEDTECHWe develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.
MORE ABOUT AQUISITIONS
AddLife´s business concept is to provide added value to its customers who are active in the healthcare sector – from research to medical care. This is done by offering high-quality, cost-effective solutions of services and products to both the private and public sectors in Europe.
MORE ABOUT ADDLIFE
